New York medical school eliminates tuition after $1B gift

A $1B bequest to New York’s Albert Einstein College of Medicine, funded by long‑held Berkshire Hathaway stock, will eliminate tuition for all medical students, prompting debate over how transformative this is for access to the profession and the wider healthcare system. Commenters explore likely effects on admissions selectivity, physician career choices, and doctor supply, while also scrutinizing whether endowment returns can sustain “free” tuition and whether such philanthropy is an inspiring model or a symptom of inadequate public funding and tax policy. Some welcome the relief from crushing medical debt; others question directing vast sums to future high earners instead of broader systemic reform.

Terminology and Headline Wording

  • Long subthread on “tuition” vs “tuition fees”:
    • In US usage, “tuition” usually means the money paid; in UK/Commonwealth it often means teaching, with “tuition fees” as the payment.
    • Some note the BBC headline (“eliminates tuition”) is British English applied to a US institution, which confuses non‑US readers.

Scale, Financing, and Endowment Math

  • Multiple back‑of‑the‑envelope calculations:
    • $1B at ~5% yield → ~$50M/year, enough to cover roughly $40k per year for ~1,250 students, close to listed tuition.
    • At that yield, the principal could remain intact and even allow some expansion of class size, assuming tuition inflation doesn’t outrun returns.
    • Others argue 10% real return is unrealistic; 5–7% nominal is more plausible given long‑run market and inflation data.
  • Concern that university cost inflation could eat the endowment unless tightly controlled.

Comparisons to Other Free‑Tuition Programs

  • NYU medical school and Kaiser Permanente’s med school already offer tuition‑free MD programs, at least for some or all cohorts, and saw huge application volumes and selectivity.
  • Examples from law and policy schools (UC Irvine, Princeton SPIA) suggest free tuition can rapidly increase competitiveness and prestige.
  • Prior experiments (Olin, Cooper Union) began tuition‑free but later had to charge, usually blamed on governance and endowment management.

Effects on Applicants, Doctors, and Workforce

  • Many expect Einstein to become far more competitive immediately.
  • Some hope debt‑free graduates will feel freer to choose research, primary care, or underserved areas.
  • Others argue that:
    • Most physicians already end up in the top 1–10% of incomes.
    • Loan‑forgiveness programs currently help channel doctors into high‑need areas; removing debt might weaken that lever.
    • Without more residency slots and better use of foreign‑trained doctors, the program mainly shifts where future doctors train rather than increasing overall supply.

Equity, Philanthropy, and Systemic Critiques

  • Enthusiastic reactions: heart‑warming story; a rare large gift that directly lowers student costs instead of funding buildings or branding.
  • Skeptical views:
    • This mostly benefits a small, already‑elite group (future high earners) rather than fixing structural health‑care or education problems.
    • Reliance on billionaire philanthropy is seen by some as evidence of tax and policy failure; several argue such fortunes shouldn’t exist or should be more heavily taxed.
    • Debate over whether investing in a single institution is “uncreative” compared to attacking insurance, admin bloat, or malpractice/tort issues system‑wide.

Governance, Incentives, and Long‑Term Risks

  • Questions about the fine print:
    • Are there legal constraints preventing the school from adding new mandatory “fees,” bloating administration, or eroding the donor’s intent?
    • Some predict that, over 10–20 years, administrative bloat or rising costs could force a retreat from free tuition unless tightly guarded.
  • One line of discussion worries “free” may reduce student commitment; others counter that medical admission standards and workload are strong filters regardless of price.

Tax and Wealth Mechanics

  • Discussion of how donating appreciated stock in the US avoids capital‑gains tax while yielding a deduction at fair market value, especially relevant if the donor inherited Berkshire Hathaway shares with stepped‑up basis.
  • Broader thread on whether massive investment windfalls reflect “merit” or luck, and what limits (if any) society should place on individual wealth and its influence.